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mutations in GJA8 and CRYGD associated with
inherited cataract
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Background: Inherited cataract is a clinically important and genetically heterogeneous cause of visual impairment.
Typically, it presents at an early age with or without other ocular/systemic signs and lacks clear phenotype-genotype
correlation rendering both clinical classification and molecular diagnosis challenging. Here we have utilized trio-based
whole exome sequencing to discover mutations in candidate genes underlying autosomal dominant cataract
segregating in three nuclear families.
Results: In family A, we identified a recurrent heterozygous mutation in exon-2 of the gene encoding γD-crystallin
(CRYGD; c.70C > A, p.Pro24Thr) that co-segregated with ‘coralliform’ lens opacities. Families B and C were found
to harbor different novel variants in exon-2 of the gene coding for gap-junction protein α8 (GJA8; c.20T > C,
p.Leu7Pro and c.293A > C, p.His98Pro). Each novel variant co-segregated with disease and was predicted in silico
to have damaging effects on protein function.
Conclusions: Exome sequencing facilitates concurrent mutation-profiling of the burgeoning list of candidate
genes for inherited cataract, and the results can provide enhanced clinical diagnosis and genetic counseling for
affected families.
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Hereditary forms of cataract constitute a clinically and
genetically heterogeneous condition affecting the ocular
lens [1-3]. Typically, inherited cataract has an early onset
(<40 years) and most cases are diagnosed at birth (con-
genital), during infancy, or during childhood accounting
for 10%–25% of all pediatric cataract cases [2]. Congeni-
tal and infantile forms of cataract are a clinically import-
ant cause of impaired visual development that accounts
for 3%–39% of childhood blindness, worldwide [4]. Des-
pite advances in surgical treatment, pediatric cataract
poses a long-term risk of postoperative complications
including secondary glaucoma, nystagmus, and retinal
detachment [5-9].
Cataract can be inherited, either, as an isolated lens
phenotype—usually with autosomal dominant transmission* Correspondence: shiels@vision.wustl.edu
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unless otherwise stated.and full penetrance—or as part of a genetic/metabolic
disorder (http://www.omim.org) involving additional ocular
defects (e.g., anterior segment dysgenesis MIM107250) and/
or systemic abnormalities (e.g., galactosemia MIM230400).
Under slit-lamp examination, inherited cataract exhibits con-
siderable inter- and intrafamilial phenotypic variation in loca-
tion, size, shape, density, progression rate, and even color of
the lens opacities [10]. Currently, genetic studies have identi-
fied over 39 genes and loci for inherited cataract, with or
without other ocular signs [1,3]. These include gene coding
for α-, β-, and γ-crystallins (e.g., CRYAA, CRYBB2, CRYGD),
α-connexins (GJA3, GJA8) and other lens membrane or
cytoskeleton proteins (e.g.,MIP, BFSP2), several transcription
factors (e.g., HSF4, PITX3), and an expanding group of
functionally divergent genes (e.g., EPHA2, TDRD7, FYCO1).
Since mutations in the same gene can cause morpho-
logically different lens opacities and mutations in differ-
ent genes can cause similar opacities, there is little
genotype-phenotype correlation for inherited cataractLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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diagnosis challenging.
Traditionally, linkage analysis in extended pedigrees has
been used to map cataract disease loci to specific chromo-
some regions and thereby limit the number of positional
candidate genes that need to be conventionally sequenced
in order to discover underlying mutations. However, the
advent of next-generation (massively parallel) sequencing
has facilitated the concurrent screening of multiple candi-
date genes in nuclear families and cases without a family
history. Here, we have undertaken affected child-parent-
trio-based whole-exome next-generation sequencing in
order to identify mutations underlying autosomal domin-
ant cataract in three nuclear families.
Results
Cataract families
We investigated three Caucasian-American pedigrees seg-
regating cataract with autosomal dominant transmission
in the absence of other ocular and/or systemic abnormal-
ities (Figures 1A and 2A,D). A review of ophthalmic
records indicated that bilateral cataract was diagnosed at
birth (congenital) or during infancy in all three families
with age-at-surgery ranging from 3 months to 1 year. In
family A, the lens opacities appeared similar to those first
described by Gunn in 1895 as resembling a piece of coral
or coralliform [11]. No clinical images of lens opacities
were available for family B or C, and none of the families
had a sufficient number of meiotic events (≥10) to supportFigure 1 Mutation analysis of inherited cataract in family A. (A) Pedig
filled symbols denote affected status. The trio of individuals I:1, I:2, and II:1
opacities in the left eye of individual II:2 just prior to surgery at 3 months o
C > A and p.Pro24Thr mutation found in affected individuals I:2, II:1, and II:2
Horizontal bars indicate the codon reading frame. (D) Amino acid alignmeindependent linkage analysis. Instead, an affected child–
parent plus spouse trio from each family was selected for
whole-exome sequencing.
Candidate genes and exome sequences
We pre-selected 39 candidate genes for inherited cataract
(Additional file 1) cited in the OMIM (http://www.omim.
org), Cat-Map (http://cat-map.wustl.edu/), and iSyTE (http://
bioinformatics.udel.edu/Research/iSyTE) databases [3,12].
The candidate list comprises genes known to be highly
expressed in the lens including those coding for cystallins,
connexins, and other lens membrane/cytoskeletal proteins,
along with several more widely expressed genes that are
associated with cataract and other limited eye/systemic
conditions. Collectively, these candidate genes span over
111,000 bps of the genome and contain 300 exons located
on chromosomes 1–13, 16, 17, 19–22, and X.
For all nine exome samples, over 98% of total paired-end
reads were mapped to the reference genome (Additional
file 2). Approximately 72%–84% of mapped reads were
present in the captured exomes, and the average mean-
mapped read-depth was 149.2X. With the exception of one
sample in family C (C-I:1), >97% of each exome achieved a
read-depth of ≥10X coverage, yielding a total of >38,900
single nucleotide polymorphisms (SNPs), of which >8,400
were non-synonymous and >1,400 were novel. For exome
C-I:1, 80.61% reached ≥10X coverage yielding a total of
34,435 SNPs (7,639 non-synonymous and 1,331 novel). In
addition, exome C-I:1 contained several more unexpectedree of family A. Squares denote males, circles denote females, and
was subject to exome sequencing. (B) Photograph of coralliform lens
f age. (C) Sanger sequence of CRYGD showing the heterozygous c.70
(upper trace) but not in the unaffected spouse I:1 (lower trace).
nt of CRYGD showing low cross-species conservation of Pro24.
Figure 2 Mutation analysis of inherited cataract in family B and family C. (A) Pedigree of family B. The trio of individuals I:1, I:2, and II:1 was
subject to exome sequencing. (B) Sanger sequence of GJA8 showing the heterozygous c.20 T > C, and p.Leu7Pro mutation found in affected
individuals I:1, II:1, II:2, and II:3 but not in the affected spouse I:2 (lower trace). Horizontal bars indicate the codon reading frame. (C) Amino acid
alignment of GJA8 showing high cross-species conservation of Leu7. (D) Pedigree showing family C. The trio of individuals I:1, I:2, and II:2 was
subject to exome sequencing. (E) Sanger sequence of GJA8 showing the heterozygous c. 293A > C and p.His98Pro mutation found in affected
individuals I:1 and II:2 (upper trace) but not in the unaffected individuals I:2 and II:1 (lower trace). Horizontal bars indicate the codon reading-frame.
(F) Amino acid alignment of GJA8 showing high cross-species conservation of His98.
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other exomes (Additional file 2). However, the reduced
coverage of exome C-I:1 did not compromise analysis of
variants in the candidate genes of interest. Coverage of the
39 candidate genes exceeded a read-depth of >10X with
three exceptions. The iron response element (IRE) of FTL
is located in the 5′-UTR (untranslated region) and was not
covered by capture probes. In addition, coverage of the sin-
gle exons that code for FOXE3 and MAF was incomplete
as previously reported [13]. We excluded mutations in all
three missing gene regions by Sanger sequencing of an
affected member of each family essentially as described
[13,14]. Collectively, from the nine exomes sequenced, 112
variants were identified in 32 of the 39 candidate genes
(Additional file 3). Of these variants, only five did not have
genome reference sequence (rs) numbers and were poten-
tially novel variants.Family A variants
A review of the exome SNPs in family A with the list of
candidate genes for cataract identified a total of 76 vari-
ants in 28 of 39 genes (Additional file 1 and Additional
file 3). Of these, six variants (two coding/missense and
four non-coding/synonymous) in five candidate genes
were found in both affected relatives and not in the un-
affected spouse. However, five of these variants associated
with four candidate genes (SLC16A12, PAX6, CRYAB,
GALK1) were excluded as disease-causing mutations as
they have minor allele frequencies (MAFs) >0.01% (range
8.5%–52.4%) in Caucasians (Additional file 3). We note
that the variant rs3740030 in SLC16A12 on chromosome
10 (chr10:91,222,287) has previously been associated with
age-related cataract [15]. As rs3740030 was first thought
to be a non-coding variant located in the 5′-UTR, the
authors proposed a complex functional mechanism that
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rs3740030 is now known to be located in exon-3 of
SLC16A12 (c.49T >G) and was predicted to result in
a non-conservative tryptophan-to-glycine substitution at
codon 17 (p.Trp17Gly). While this variant was also pre-
dicted in silico to have a damaging effect on protein func-
tion (PolyPhen-2 score =0.997), it had a MAF value of 8.5%
in Caucasians, suggesting that it is unlikely to be disease
causing in family A. The remaining variant, rs28931605, oc-
curred in exon-2 of CRYGD (c.70C >A) on chromosome 2
(chr2:208,989,018) and was predicted to result in the non-
conservative substitution of proline-to-threonine at codon
24 (p.Pro24Thr) (Table 1). While this variant was predicted
in silico to be tolerated, benign, or neutral with respect to
protein function (Table 2), it has been previously associated
with autosomal dominant cataract in multiple families
(Additional file 4). The p.Pro24Thr variant has also been
documented as p.Pro23Thr based on N-terminal process-
ing of the of the CRYGD protein that removes the initiator
methionine residue. Here, we have adopted the recom-
mended nomenclature in order to avoid confusion and
re-numbering of other mutations in CRYGD associated
with inherited cataract [16]. Sanger sequencing of all four
members of family A (Figure 1A,C) confirmed that the
p.Pro24Thr variant co-segregated with disease providing
further support for its role as a causal mutation.
Family B variants
A review of the exome SNPs in family B with the candi-
date gene list, revealed a total of 73 variants in 22 of 39
genes (Additional file 1 and Additional file 3). Only 13
of these variants (12 non-coding or synonymous) associ-
ated with 7 of the candidate genes were found in both
affected relatives and not in the unaffected spouse. All
12 non-coding or synonymous variants had MAF
values >0.01% (range 0.4%–45.80%) and were effectively
excluded as disease-causing mutations. The remaining
variant was located in exon-2 of GJA8 (c.20T > C) on
chromosome 1 (chr1:147,380,102) and was predicted to
result in the substitution of leucine-to-proline at codon
7 (p.Leu7Pro) (Table 1). The p.Leu7Pro substitution rep-
resented a relatively conservative change with the non-
polar, side-chain of leucine ([CH3]2-CH-CH2-) replaced
by the unusual non-polar, side-ring of proline (−CH2-
CH2-CH2-). However, Leu7 is phylogenetically conservedTable 1 Summary of mutations detected by exome sequencin





A (3) chr2:208,989,018 CRYGD (1412) 2
B (4) chr1:147,380,102 GJA8 (2703) 2
C (2) chr1:147,380,375 GJA8 (2703) 2
*Allele frequencies for European Americans listed on the Exome Variant Server.in GJA8 (Figure 2C), and the Pro7 substitution was
predicted in silico to have probably damaging effects
on protein function (Table 2). Sanger sequencing of
all five members of family B (Figure 2A,B) confirmed
that the novel p.Leu7Pro variant in GJA8 co-segregated
with cataract further suggesting that it was the disease-
causing mutation.
Family C variants
A review of the exome SNPs in family C using the can-
didate gene list yielded a total of 82 variants in 23 of the
39 genes (Additional file 1 and Additional file 3). How-
ever, only three of these variants associated with the
candidate genes, WFS1, BFSP1, and GJA8, were present
in both affected relatives but not in the unaffected
spouse. The variants associated with WFS1 (rs734312)
and BFSP1 (rs2281207) had MAF values of 54.69% and
25.74%, respectively, and were excluded as causative
mutations. The remaining variant occurred in exon-2 of
GJA8 (c.293A > C) on chromosome 1 (chr1:147,380,375)
and was predicted to result in a non-conservative substi-
tution of histidine-to-proline at codon 98 (p.His98Pro)
(Table 1). Histidine 98 is phylogenetically conserved across
species (Figure 2F), and this variant was also predicted
to have damaging effects on protein function using six
mutation prediction programs (Table 2). Sanger sequen-
cing of all four members of family C (Figure 2D,E)
confirmed that the novel p.His98Pro variant in GJA8
co-segregated with cataract, consistent with it being the
disease-causing mutation.
Discussion
Several recent studies have employed exome sequencing
of index patients or probands in multiple families in
order to discover mutations in candidate genes under-
lying autosomal dominant and recessive forms of cata-
ract [13,17-19]. In this study, we have used trio-based
exome sequencing to uncover a recurrent missense mu-
tation in CRYGD (p.Pro24Thr) and two novel missense
mutations in GJA8 (p.Leu7Pro, p.His98Pro) associated
with autosomal dominant cataract in three nuclear
families. Child–parent trios offer the initial benefit of
co-segregation testing during exome variant analysis, but
this advantage may be offset in larger cohorts of families
by the additional sequencing costs. The p.Pro24Thrg of trios from families A, B, and C
cDNA variant Protein variant Allele frequency
(EVS)*
Status
c.70C > A p.Pro24Thr 0/8,600 Recurrent
(Additional file 5)
c.20T > C p.Leu7Pro 0/8,600 Novel
c.293A > C p.His98Pro 0/8,600 Novel
Table 2 In silico predictions of functional effects for the three mutations identified in this study
Prediction program CRYGD GJA8 GJA8
c.70C > A c.20T > C c.293A > C
p.Pro24Thr p.Leu7Pro p.His98Pro
SIFT Value (<0.05) 0.10 0.00 0.00
Prediction Tolerated Not tolerated Not tolerated
Polyphen-2 Score 0.084 0.991 1.000
Prediction Benign Probably damaging Probably damaging
PMUT NN output 0.0936 0.8749 0.7822
Reliability 8 7 5
Prediction Neutral Pathological Pathological
PANTHER subPSEC (<−3) −2.35974 −4.3388 −3.98807
Pdeleterious (>0.5) 0.34519 0.79148 0.72871
PON-P2 Probability for pathogenicity 0.479 0.947 0.444
Standard error 0.332 0.050 0.090
Prediction Unknown Pathogenic Unknown
MutPred Probability of deleterious mutation 0.840 0.918 0.889
Molecular mechanisms disrupted Loss of stability (p =0.0067)
Gain of disorder (p =0.0099)
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14 different families, mostly segregating coralliform cata-
ract that affects more than 133 individuals with varied
ethnic backgrounds and constitutes the most recurrent
missense mutation in a crystallin gene to be associated
with inherited cataract (Additional file 4). The novel muta-
tions found in GJA8 increase the mutation spectrum of
this connexin gene to at least 32 different mutations segre-
gating in 38 families making it one of the most common
non-crystallin genes to be associated with inherited
cataract in humans (Additional file 5).
CRYGD (MIM: 123690) consists of three exons and
encodes γD-crystallin—a hydrophylic protein of 174
amino acids that is characterized by two βγ-crystallin
domains each formed by two repeat Greek-key motifs of
approximately 40 residues. CRYGD is expressed at high
concentrations in fiber cells of mammalian lenses and
plays an important structural role in establishing lens
transparency and gradient refractive index [20]. Proline
at position 24 is located within the first Greek-key motif
of human CRYGD but is not well conserved across spe-
cies (replaced by serine in the mouse and threonine in
the zebrafish). Consequently, in silico analysis predicted
that the Pro24Thr substitution was benign (Table 2).
Further, NMR-spectroscopy and X-ray crystallography
have indicated that the Pro24 and Thr24 proteins are
structurally similar overall [21,22]. However, the Thr24
mutant exhibits local conformational and dynamic dif-
ferences that may initiate aggregation or polymerization
and in vitro experiments have shown that the Thr24protein exhibits reduced solubility—a property that is
likely to trigger cataract formation [23-25].
GJA8 (MIM: 600897) comprises two exons with exon-
2 coding for the entire 433 amino acid residues of gap-
junction protein α8 or connexin 50. GJA8 contains four
transmembrane domains that are joined by two extracel-
lular loops and one cytoplasmic loop and flanked by
cytoplasmic N- and C-termini. By forming hexamers, or
hemi-channels, that can dock between adjacent cells to
create gap-junction channels, GJA8 plays an important
role in lens intercellular communication [26]. Of the 32
known coding mutations in GJA8, 30 result in missense
substitutions that, with one exception, are associated with
autosomal dominant cataract, and the remaining two are
frameshift mutations associated with autosomal recessive
cataract (Additional file 5). Most of the missense substitu-
tions are located within the N-terminal half of the protein,
which also contains the conserved connexin domain
(pfam00029; amino acids 3–109). The novel p.Leu7Pro
substitution found in family B is the first to be located at
the cytosolic N-terminal end of human GJA8. Support for
its pathogenicity in humans is provided by the SHR-Dca
rat strain, which inherits semi-dominant cataract [27].
Heterozygous (+/Dca) mutants develop nuclear pulveru-
lent opacities and smaller eyes than wild-type, while
homozygotes (Dca/Dca) present with severe microphthal-
mia and a hypoplastic lens. The underlying mutation has
been identified as a missense mutation in GJA8 (c.20T >A)
that is predicted to result in a non-conservative
p.Leu7Gln substitution. Both the rat p.Leu7Gln and
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highly conserved leucine residue with uncharged amino
acids, suggesting that they may exert similar deleterious
effects on GJA8 function.
The novel p.His98Pro mutation identified in family C,
is located near the junction of the second transmem-
brane domain with the cytoplasmic loop of GJA8. Four
other mutations, p.Val79Leu, p.Pro88Ser, p.Pro88Gln,
and p.Pro88Thr, have previously been localized to the
second transmembrane domain (Additional file 5). Func-
tional expression studies of the relatively conservative
p.Val79Leu substitution results in functional gap-junction
channels with altered voltage-gating and a reduction in
the single-channel open probability [28]. By contrast, nei-
ther of the non-conservative p.Pro88Gln and p.Pro88Ser
substitutions was targeted to the plasma membrane, with
the former accumulating in the endoplasmic-reticulum
(ER)-Golgi-complex and the latter forming discrete cyto-
plasmic inclusions [26]. Based on the non-conservative
nature of the p.His98Pro substitution, we speculate that
this mutant will also fail to reach the plasma membrane
and form functional gap-junction channels
Conclusions
Exome sequencing provides a rational approach to con-
currently screen over 39 candidate genes for inherited
cataract in nuclear families or even sporadic cases. In
addition, exome sequencing may enable the discovery of
novel genes underlying inherited cataract and, poten-
tially, genes associated with age-related cataract. How-
ever, considerable supporting evidence (e.g., additional
mutations, functional expression in vitro, and/or an ani-
mal model) will be required to verify disease causation.
In a clinical setting, results from exome sequencing are
unlikely to be ‘clinically actionable’ with respect to surgi-
cal treatment and subsequent management of inherited
cataract. However, such data can contribute to a gene-
centric clinical classification of inherited cataract and




Ethical approval for this study was obtained from the
Washington University Human Research Protection Office
(HRPO), and written informed consent was provided by all
participants prior to enrollment in accordance with the te-
nets of the Declaration of Helsinki and Health Insurance
Portability and Accountability Act (HIPAA) regulations.
Family participants
Three Caucasian-American pedigrees segregating auto-
somal dominant cataract were ascertained through oph-
thalmic records in the Department of Ophthalmology andVisual Sciences at Washington University School of Medi-
cine. Blood samples were obtained from available family
members including a spouse (Figures 1 and 2). Leukocyte
genomic DNA was purified using the Gentra Puregene
Blood kit (Qiagen, Valencia, CA) and quantified by absorb-
ance at 260 nm (NanoDrop 2000, Wilmington, DE).
Exome sequencing
Whole exome capture was achieved using the SureSelect
Human All Exon V5 (50.4 Mb) Kit, according to manu-
facturer’s instructions (Agilent Technologies). Briefly,
genomic DNA (3 μg) was fragmented (150–200 bp) by
acoustic shearing, ligated to adapter primers, and PCR-
amplified. Following denaturation (95°C, 5 min), ampli-
fied DNA-fragment libraries (~500 ng) were hybridized
in a solution under high stringency (65°C, 24 h) with
biotinylated RNA capture probes (~120 bp). Resulting
DNA/RNA hybrids were recovered by streptavidin-coated
magnetic bead separation (Dynal, Invitrogen, Carlsbad,
CA). Captured DNA was eluted (NaOH) and then subject
to solid phase (flow-cell) next-generation (massively paral-
lel) sequencing on a HiSeq2000 System (Illumina, San
Diego, CA) using the Illumina Multiplexing Sample Prepar-
ation Oligo-nucleotide Kit and the HiSeq 2000 Paired-End
Cluster Generation Kit according to the manufacturer’s in-
structions. Briefly, hybrid-capture libraries were amplified
to add indexing (identifying) tags and sequencing primers
then subjected to paired-end (2 × 101 bp read length),
multiplex sequencing-by-synthesis using fluorescent, cyclic
reversible (3′-blocked) terminators. A pool of three exome
samples (representing a family trio) was sequenced in a
single lane of the sequencer’s flow-cell.
Exome variant analysis
Raw sequence data was aligned to the human reference
genome (build hg19) by NovoalignMPI (www.novocraft.
com), and sequence variants called using the Sequence
Alignment/Map format (SAMtools) and Picard programs
(http://samtools.sourceforge.net/) and further annotated
using SeattleSeq (http://snp.gs.washington.edu/SeattleSeq
Annotation138/). Target coverage and read-depth were
reviewed by the Integrated Genomics Viewer (IGV; http://
www.broadinstitute.org/igv/). Variants were filtered using
the Ingenuity variant analysis website (IVA http://ingenuity.
com) or the gNOME project pipeline (http://gnome.tchlab.
org/) [29]. Identified variants in the pre-selected candidate
genes (Additional file 1) were then reviewed for presence/
absence and frequency in various websites including dbSNP
(http://www.ncbi.nlm.nih.gov/snp/), 1000 genomes (http://
www.1000genomes.org/), and the Exome Variant Server
database (http://evs.gs.washington.edu/EVS/). The predicted
effect on protein function was analyzed using the SIFT
(http://sift.jcvi.org), PolyPhen-2 (http://genetics.bwh.harvard.
edu/pph2/), PMUT (http://mmb2.pcb.ub.es:8080/PMut/),
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(http://www.pantherdb.org/tools/csnpScoreForm.jsp), and
MutPred (http://mutpred.mutdb.org/) in silico mutation
prediction programs [30-34].
Sanger sequencing
Genomic DNA (2.5 ng/μl, 10 μl reactions) was amplified
(35 cycles) in a GeneAmp 9700 thermal cycler using Top
Taq mastermix kit (Qiagen) and 20 pmol of gene-specific
primers (Additional file 6). Resulting PCR amplicons were
enzyme-purified with ExoSAP-IT (USB Corporation,
Cleveland, OH). The purified amplicons were direct cycle-
sequenced in both directions with BigDye Terminator
Ready Reaction Mix (v3.1)(Applied Biosystems, Grand
Island, NY) containing M13 forward or reverse sequencing
primers, then ethanol precipitated and detected by capillary
electrophoresis on a 3130xl Genetic Analyzer running
Sequence Analysis (v.6.0) software (Applied Biosystems)
and Chromas (v2.23) software (Technelysium, Tewantin,
Queensland, Australia).
Additional files
Additional file 1: Table S1. Candidate genes for inherited cataract
evaluated in this study.
Additional file 2: Table S2. Sample metrics for exome sequencing of
trios from families A, B, and C.
Additional file 3: Table S3. Exome sequencing variants found in
candidate genes for inherited cataract (Additional file 1, Table S1) in
family trios A, B, and C.
Additional file 4: Table S4. Recurrence of the p.Pro24Thr mutation in
CRYGD associated with autosomal dominant cataract.
Additional file 5: Table S5. Mutation profile of GJA8.
Additional file 6: Table S6. PCR primers used for Sanger sequencing of
mutations found in CRYGD and GJA8. Each primer used was tailed with
M13 sequences to aid in Sanger sequencing. The forward primers were
tagged with ‘tgtaaaacgacggccagt’ and the reverse primers with
‘caggaaacagctatgacc’.
Abbreviations
OMIM: Online Mendelian Inheritance in Man; MAF: Minor allele frequency;
SHR-Dca: Spontaneously hypertensive rat-Dominant cataract; NMR: Nuclear
magnetic resonance.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
DSM and TMB were involved in acquisition and analysis of exome
sequencing data and bioinformatics analyses. SMC coordinated
ascertainment and recruitment of patients and was involved in acquisition
and analysis of clinical data. DSM and AS conceived the study, participated
in its design and coordination, and drafted the manuscript. All authors read
and approved the final manuscript.
Acknowledgements
We thank the families for their participation in this study and the Genome
Technology Access Center (GTAC) at Washington University School of
Medicine for help with genomic analysis. GTAC is partially supported by
National Institutes of Health (NIH) grants P30 CA91842 and UL1 TR000448.
This work was supported by NIH grants EY012284 (to A.S.) and EY02687(Core Grant for Vision Research) and by an unrestricted grant to the
Department of Ophthalmology and Visual Sciences from Research to Prevent
Blindness (RPB).
Received: 27 August 2014 Accepted: 23 October 2014
References
1. Shiels A, Bennett T, Hejtmancik J: Cat-Map: putting cataract on the map.
Mol Vis 2010, 16:2007–2015.
2. Trumler A: Evaluation of pediatric cataracts and systemic disorders.
Curr Opin Ophthalmol 2011, 22:365–379.
3. Shiels A, Hejtmancik JF: Genetics of human cataract. Clin Genet 2013,
84:120–127.
4. Mickler C, Boden J, Trivedi RH, Wilson ME: Pediatric cataract. Pediatr Ann
2011, 40:83–87.
5. Mataftsi A, Haidich AB, Kokkali S, Rabiah PK, Birch E, Stager DRJ, Cheong-Leen R,
Singh V, Egbert JE, Astle WF, Lambert SR, Amitabh P, Khan AO, Grigg J, Arvanitidou
M, Dimitrakos SA, Nischal KK: Postoperative glaucoma following infantile
cataract surgery: an individual patient data meta-analysis. JAMA Ophthalmol
2014, doi:10.1001/jamaophthalmol.2014.1042. Published online June 12, 2014.
6. Lambert SR, Purohit A, Superak HM, Lynn MJ, Beck AD: Long-term risk of
glaucoma after congenital cataract surgery. Am J Ophthalmol 2013,
156:355–361. e352.
7. Ruddle JB, Staffieri SE, Crowston JG, Sherwin JC, Mackey DA: Incidence and
predictors of glaucoma following surgery for congenital cataract in the
first year of life in Victoria, Australia. Clin Experiment Ophthalmol 2013,
41:653–661.
8. Young MP, Heidary G, VanderVeen DK: Relationship between the timing of
cataract surgery and development of nystagmus in patients with
bilateral infantile cataracts. J AAPOS 2012, 16:554–557.
9. Haargaard B, Andersen EW, Oudin A, Poulsen G, Wohlfahrt J, la Cour M,
Melbye M: Risk of retinal detachment after pediatric cataract surgery.
Invest Ophthalmol Vis Sci 2014, 55:2947–2951.
10. Amaya L, Taylor D, Russell-Eggitt I, Nischal KK, Lengyel D: The morphology
and natural history of childhood cataracts. Surv Ophthalmol 2003,
48:125–144.
11. Gunn RM: Peculiar coralliform cataract with crystals in the lens. Trans Ophthalmol
Soc UK 1895, XV:119.
12. Lachke SA, Ho JW, Kryukov GV, O’Connell DJ, Aboukhalil A, Bulyk ML, Park PJ,
Maas RL: iSyTE: integrated Systems Tool for Eye gene discovery.
Invest Ophthalmol Vis Sci 2012, 53:1617–1627.
13. Reis LM, Tyler RC, Muheisen S, Raggio V, Salviati L, Han DP, Costakos D,
Yonath H, Hall S, Power P, Semina EV: Whole exome sequencing in
dominant cataract identifies a new causative factor, CRYBA2, and a
variety of novel alleles in known genes. Hum Genet 2013, 132:761–770.
14. Bennett TM, Maraini G, Jin C, Sun W, Hejtmancik JF, Shiels A: Noncoding
variation of the gene for ferritin light chain in hereditary and
age-related cataract. Mol Vis 2013, 19:835–844.
15. Zuercher J, Neidhardt J, Magyar I, Labs S, Moore AT, Tanner FC, Waseem N,
Schorderet DF, Munier FL, Bhattacharya S, Berger W, Kloeckener-Gruissem B:
Alterations of the 5′untranslated region of SLC16A12 lead to age-related
cataract. Invest Ophthalmol Vis Sci 2010, 51:3354–3361.
16. den Dunnen JT, Antonarakis SE: Nomenclature for the description of
human sequence variations. Hum Genet 2001, 109:121–124.
17. Aldahmesh MA, Khan AO, Mohamed JY, Hijazi H, Al-Owain M, Alswaid A,
Alkuraya FS: Genomic analysis of pediatric cataract in Saudi Arabia
reveals novel candidate disease genes. Genet Med 2012, 14:955–962.
18. Sun W, Xiao X, Li S, Guo X, Zhang Q: Exome sequencing of 18 Chinese
families with congenital cataracts: a new sight of the NHS gene.
PLoS One 2014, 9:e100455.
19. Prokudin I, Simons C, Grigg JR, Storen R, Kumar V, Phua ZY, Smith J,
Flaherty M, Davila S, Jamieson RV: Exome sequencing in developmental
eye disease leads to identification of causal variants in GJA8, CRYGC,
PAX6 and CYP1B1. Eur J Hum Genet 2014, 22:907–915.
20. Slingsby C, Wistow GJ, Clark AR: Evolution of crystallins for a role in the
vertebrate eye lens. Protein Sci 2013, 22:367–380.
21. Jung J, Byeon IJ, Wang Y, King J, Gronenborn AM: The structure of the
cataract-causing P23T mutant of human gammaD-crystallin exhibits
distinctive local conformational and dynamic changes. Biochemistry 2009,
48:2597–2609.
Mackay et al. Human Genomics 2014, 8:19 Page 8 of 8
http://www.humgenomics.com/content/8/1/1922. Ji F, Koharudin LM, Jung J, Gronenborn AM: Crystal structure of the
cataract-causing P23T gammaD-crystallin mutant. Proteins 2013,
81:1493–1498.
23. Mackay D, Andley U, Shiels A: A missense mutation in the gammaD
crystallin gene (CRYGD) associated with autosomal dominant “coral-like”
cataract linked to chromosome 2q. Mol Vis 2004, 10:155–162.
24. Evans P, Wyatt K, Wistow GJ, Bateman OA, Wallace BA, Slingsby C: The P23T
cataract mutation causes loss of solubility of folded γD-crystallin.
J Mol Biol 2004, 343:435–444.
25. Pande A, Ghosh KS, Banerjee PR, Pande J: Increase in surface
hydrophobicity of the cataract-associated P23T mutant of human
gammaD-crystallin is responsible for its dramatically lower, retrograde
solubility. Biochemistry 2010, 49:6122–6129.
26. Beyer E, Ebihara L, Berthoud V: Connexin mutants and cataracts. Front Pharmacol
2013, 4:43.
27. Liska F, Chylíková B, Martínek J, Kren V: Microphthalmia and cataract in
rats with a novel point mutation in connexin 50–L7Q. Mol Vis 2008,
7:828–828.
28. Rubinos C, Villone K, Mhaske P, White TW, Srinivas M: Functional effects of
Cx50 mutations associated with congenital cataracts. Am J Physiol Cell Physiol
2014, 306:C212–C220.
29. Lee I-H, Lee K, Hsing M, Choe Y, Park J-H, Kim SH, Bohn JM, Neu MB, Hwang
KB, Green RC, Kohane IS, Kong SW: Prioritizing disease-linked variants, genes,
and pathways with an interactive whole-genome analysis pipeline.
Hum Mut 2014, 35:537–547.
30. Ferrer-Costa C, Gelpi JL, Zamakola L, Parraga I, de la Cruz X, Orozco M:
PMUT: a web-based tool for the annotation of pathological mutations
on proteins. Bioinformatics 2005, 21:3176–3178.
31. Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, Daverman R, Diemer
K, Muruganujan A, Narechania A: PANTHER: a library of protein families
and subfamilies indexed by function. Genome Res 2003, 13:2129–2141.
32. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P,
Kondrashov AS, Sunyaev SR: A method and server for predicting
damaging missense mutations. Nat Methods 2010, 7:248–249.
33. Li B, Krishnan VG, Mort ME, Xin F, Kamati KK, Cooper DN, Mooney SD,
Radivojac P: Automated inference of molecular mechanisms of disease
from amino acid substitutions. Bioinformatics 2009, 25:2744–2750.
34. Sim N-L, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC: SIFT web server:
predicting effects of amino acid substitutions on proteins. Nucl Acids Res
2012, 40:W452–W457.
doi:10.1186/s40246-014-0019-6
Cite this article as: Mackay et al.: Exome sequencing identifies novel and
recurrent mutations in GJA8 and CRYGD associated with inherited
cataract. Human Genomics 2014 8:19.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
